Agilent Introduces Breakthrough Analytical Solutions at Executive Technical Summit

2/15/2021

Agilent Technologies Inc. (NYSE: A) today announced the successful conclusion and key outcomes of their 2021 Executive Technical Summit, held virtually on February 12. The summit was established to provide a forum for Agilent and its partners to discuss recent trends in the industry, new challenges faced by customers, and how Agilent can partner with them to provide solutions that are customized to meet these challenges.

In preparation for this year's summit, Agilent interacted with its external partners as well as opinion leaders in the pharma industry, sharing some of their key products capable of addressing the needs and challenges of the pharma/biopharma industry today. Included in these discussions were recent innovations designed to alleviate IT and data management challenges and improve their ability to meet project deadlines and strengthen client relationships. The development of these and other featured solutions was driven in part by customer feedback received during similar prior events.
 
“We truly value the voice of our customers as it gives us insights about their emerging business model, new opportunities, and challenges, which are essential for fueling further innovation at Agilent," said Samir Vyas, Country Manager for Agilent India. "The Executive Technical Summit has been a promising platform for enabling open discussions with our expert team around the actions we’ve taken and customer feedback on new methods and technologies. We continue to look for opportunities beyond our current offerings and seek ways to leverage our industry-leading R&D and M&A strategies to provide compelling portfolio solutions to our customers. The Agilent team presented new capabilities to support the emerging challenges of laboratories and it was very encouraging to hear that our customers value our new solutions.”
 
“I am extremely pleased to connect with our customers in India through our Executive Technical Summit platform," added Maria Angeles Diaz, Agilent EMEAI Sales Vice President and General Manager. "We missed the opportunity in 2020 due to various global travel restrictions, but we have proposed this virtual engagement format to allows us to continue to collaborate in an efficient and inspiring way. Our commitment to customers is to provide trusted answers to solve their key challenges, so getting the opportunity to talk about new emerging trends, understand how the situation of 2020 has impacted their business models, and hear their perspective about the industry for the mid/long term is an essential enabler to our mutual success.”

Topics discussed at the summit included: ways to ensure accurate analysis of biomolecules and vaccines using the Agilent 1290 Bio LC; strategies for increasing productivity and compliance through automation of data management with SLIMS; meeting upcoming regulatory requirements in materials identification using tools such as Vaya Raman; and orthogonality in materials characterization (solid state) by LDIR. Agilent has also developed its first-ever instrument subscription program, designed to meet the needs of customers with dynamic businesses who want the latest technology backed by the industry’s best service and support. Agilent Instrument Subscriptions provides customers access to the technology they need when they need it, and with the flexibility and affordability that matches their evolving scientific and financial needs.

 

News Articles More

WhatsApp